Literature DB >> 22737278

Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors.

Mijoon Lee1, Masahiro Ikejiri, Dennis Klimpel, Marta Toth, Mana Espahbodi, Dusan Hesek, Christopher Forbes, Malika Kumarasiri, Bruce C Noll, Mayland Chang, Shahriar Mobashery.   

Abstract

An extensive structure-activity relationship study with the template of <span class="Chemical">2-(4-phenoxyphenylsulfonylmethyl)thiirane (1), a potent and highly selective inhibitor for <span class="Species">human gelatinases, is reported herein. Syntheses of 65 new analogs, each in multistep processes, allowed for exploration of key structural components of the molecular template. This study reveals that the presence of the sulfonylmethylthiirane and the phenoxyphenyl group were important for gelatinase inhibition. However, para- and some meta-substitutions of the terminal phenyl ring enhanced inhibitory activity, and led to improve metabolic stability. This agrees with the result from metabolism studies with compound 1 that the primary route of biotransformation is oxidation, mainly at the para position of the phenyl ring and alpha position of the sulfonyl group in the aliphatic side chain.

Entities:  

Year:  2012        PMID: 22737278      PMCID: PMC3379896          DOI: 10.1021/ml300050b

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  18 in total

1.  Potent mechanism-based inhibitors for matrix metalloproteinases.

Authors:  Masahiro Ikejiri; M Margarida Bernardo; R Daniel Bonfil; Marta Toth; Mayland Chang; Rafael Fridman; Shahriar Mobashery
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

2.  Sulfonate-containing thiiranes as selective gelatinase inhibitors.

Authors:  Sebastian A Testero; Mijoon Lee; Rachel T Staran; Mana Espahbodi; Leticia I Llarrull; Marta Toth; Shahriar Mobashery; Mayland Chang
Journal:  ACS Med Chem Lett       Date:  2010-12-13       Impact factor: 4.345

3.  Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor.

Authors:  R Daniel Bonfil; Aaron Sabbota; Sanaa Nabha; M Margarida Bernardo; Zhong Dong; Hong Meng; Hamilto Yamamoto; Sreenivasa R Chinni; Int Taek Lim; Mayland Chang; Lusia C Filetti; Shahriar Mobashery; Michael L Cher; Rafael Fridman
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

4.  Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.

Authors:  Michelle D Martin; Kathy J Carter; Sharon R Jean-Philippe; Mayland Chang; Shahriar Mobashery; Sophie Thiolloy; Conor C Lynch; Lynn M Matrisian; Barbara Fingleton
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

5.  Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage.

Authors:  Zongduo Guo; Xiaochuan Sun; Zhaohui He; Yong Jiang; Xiaodong Zhang; John H Zhang
Journal:  Neurol Res       Date:  2009-08-21       Impact factor: 2.448

6.  Metabolism of a highly selective gelatinase inhibitor generates active metabolite.

Authors:  Mijoon Lee; Adriel Villegas-Estrada; Giuseppe Celenza; Bill Boggess; Marta Toth; Gloria Kreitinger; Christopher Forbes; Rafael Fridman; Shahriar Mobashery; Mayland Chang
Journal:  Chem Biol Drug Des       Date:  2007-10-10       Impact factor: 2.817

7.  A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition.

Authors:  Mijoon Lee; Giuseppe Celenza; Bill Boggess; Jennifer Blase; Qicun Shi; Marta Toth; M Margarida Bernardo; William R Wolter; Mark A Suckow; Dusan Hesek; Bruce C Noll; Rafael Fridman; Shahriar Mobashery; Mayland Chang
Journal:  Chem Biol Drug Des       Date:  2009-02       Impact factor: 2.817

8.  Metabolism of (4-phenoxyphenylsulfonyl) methylthiirane, a selective gelatinase inhibitor.

Authors:  Giuseppe Celenza; Adriel Villegas-Estrada; Mijoon Lee; Bill Boggess; Christopher Forbes; William R Wolter; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  Chem Biol Drug Des       Date:  2008-03       Impact factor: 2.817

9.  Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.

Authors:  Christopher Forbes; Qicun Shi; Jed F Fisher; Mijoon Lee; Dusan Hesek; Leticia I Llarrull; Marta Toth; Michael Gossing; Rafael Fridman; Shahriar Mobashery
Journal:  Chem Biol Drug Des       Date:  2009-10-06       Impact factor: 2.817

10.  A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.

Authors:  Zezong Gu; Jiankun Cui; Stephen Brown; Rafael Fridman; Shahriar Mobashery; Alex Y Strongin; Stuart A Lipton
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.709

View more
  5 in total

1.  O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.

Authors:  Major Gooyit; Wei Song; Kiran V Mahasenan; Katerina Lichtenwalter; Mark A Suckow; Valerie A Schroeder; William R Wolter; Shahriar Mobashery; Mayland Chang
Journal:  J Med Chem       Date:  2013-10-08       Impact factor: 7.446

2.  Acceleration of diabetic wound healing using a novel protease-anti-protease combination therapy.

Authors:  Ming Gao; Trung T Nguyen; Mark A Suckow; William R Wolter; Major Gooyit; Shahriar Mobashery; Mayland Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

3.  Copper-catalyzed synthesis of phenol and diaryl ether derivatives via hydroxylation of diaryliodoniums.

Authors:  Lianbao Ye; Chao Han; Peiqi Shi; Wei Gao; Wenjie Mei
Journal:  RSC Adv       Date:  2019-07-10       Impact factor: 4.036

4.  Synthesis of cis-thiiranes as diastereoselective access to epoxide congeners via 4π-electrocyclization of thiocarbonyl ylides.

Authors:  Su-Min Song; Jaeseong Jin; Jun-Ho Choi; Won-Jin Chung
Journal:  Nat Commun       Date:  2022-08-16       Impact factor: 17.694

5.  Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor (R)-ND-336.

Authors:  Charles Edwin Raja Gabriel; Trung T Nguyen; Emanuele Marco Gargano; Jed F Fisher; Mayland Chang; Shahriar Mobashery
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.